23
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

A Systematic Review of Quality of Life in Patients with Short Bowel Syndrome and Their Caregivers

ORCID Icon, , , , &
Pages 1217-1230 | Received 20 Oct 2023, Accepted 29 Apr 2024, Published online: 02 Jul 2024
 

Abstract

Purpose

Understanding the quality of life and the factors that influence it for patients with short bowel syndrome (SBS) and their caregivers is of utmost importance in order to enhance their well-being. Therefore, This study aimed to provide a comprehensive understanding of the impact of SBS on patients and their caregivers, as well as its associated factors, by synthesizing the available evidence.

Methods

A systematic review of the literature was done using PubMed, Embase databases, CNKI, and ISPOR conference papers. Included articles were manually searched to identify any other relevant studies. Quality was assessed using appropriate Joanna Briggs Institute critical appraisal tools.

Results

This review included 16 studies, comprising 15 observational studies and 1 randomized controlled trial. The findings revealed that the QoL of patients with SBS was lower than that of the general population regarding physical functioning and psychological domain. Meanwhile, caregivers experienced challenges in maintaining their QoL. The QoL of SBS patients was found to be influenced by various factors such as treatment, age, sex, stoma, and small intestine length. Among them, the treatment is the most noteworthy factor that can be effectively improved through external interventions.

Conclusion

While numerous studies have provided insights into the compromised QoL experienced by individuals with SBS and their caregivers, there remains a scarcity of large-sample quantitative investigations examining the determinants of QoL. The existing body of literature on caregivers is also notably deficient.

Acknowledgments

The authors would like to acknowledge Anwesha Mandal, Lakshmi Settu, and Dr. Ramandeep Singh, PhD of Indegene Ltd, for their medical writing and editorial support provided under guidance of authors.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

Yanan Sheng is employee of Takeda (China) International Trading Co and grants from Takeda Pharmaceutical Company Limited. The authors report no other conflicts of interest in this work.

Additional information

Funding

This publication was funded by Takeda (China) International Trading Co.